Google TrendGREEN CARD (500+) — Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Daniel Spratt, MD" (30 stories)

Top Headline Story

Adjuvant Versus Early Salvage Radiotherapy After Prostatectomy - Piet Ost & Daniel Spratt
Lead StoryUroTodaygeneral
Jun 27

Adjuvant Versus Early Salvage Radiotherapy After Prostatectomy - Piet Ost & Daniel Spratt

<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxONzR2Vy1TTklNSkMxWkhFRHhaUEtkQV92QXdvdkJNNUNyd3E3QmxiRGVFclczZk1VR19DekhydXIxVWROOEZ4MTU3S1QyaTh3WHJUQUNEWm45WVpYdDZnY2ItTzg5dTBZWXRhZEpJMlI0cTR0cG5mMjNNVzBsQ2FCc1ppNVBxR2N1NmxuZkIyS05URDg4c25zdFJjSUJhc2F0UldPMzVxZWpRVkJ2NlhYNjdmT3l4SFRROWs3YUttUVRWOUsxdzYwbG9EN3NXUUFmUXd3dFRLM2RUUG9Td2lCOU9BVUdRZzg?oc=5" target="_blank">Adjuvant Versus Early Salvage Radiotherapy After Prostatectomy - Piet Ost & Daniel Spratt</a>  <font color="#6f6f6f">UroToday</font>

Real-time search volume
500+18m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

10000+18m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

1000+18m ago

sony playstation

PS2 Discs Now Load on Jailbroken PS5 Consoles Through PS5SX2 Emulator

100+18m ago

loki

Loki Star Addresses Avengers: Doomsday Return Status After New Tva Post-Credits Scene

Search Results for "Daniel Spratt, MD"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Closing Risk Stratification Gaps in Localized Prostate Cancer With AI
Urology Timestech

Closing Risk Stratification Gaps in Localized Prostate Cancer With AI

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxPNW1iY2JnenIwMm9WSUV0TWZ3RWdBUVlNSHBvODdNTU5tN19OZjh5NnNQVmNLUm5HUldkUUV6QUE4Si1HMy1iYTVlSG41UVRSZlRiNWU4R09pMENrcXdfaHBCOFBLMlpKX01Na25jOVRNX0dnZXBBUDZuVmpKSlV1UGVVbW9tNk1UaUJTTWpPbUpXdlF4Q05xRzR0cmVrWFJKdGVFRmpR?oc=5" target="_blank">Closing Risk Stratification Gaps in Localized Prostate Cancer With AI</a>  <font color="#6f6f6f">Urology Times</font>

Daniel Spratt, MD
Endocrine.orggeneral

Daniel Spratt, MD

<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE8wdkVwcVAyWllzV2Vic19MbFo4V1R0dktQMkZpM0hIOFNXQnY4QnBPb1lYYU9FS2VjbHRrTnBScFVMM2RYejFlYnc3MzE2VlJudGpfU0xuRzd6S2QzY1NlSHRaTkI4VGtacVhUWTJybw?oc=5" target="_blank">Daniel Spratt, MD</a>  <font color="#6f6f6f">Endocrine.org</font>

Radiation to the Primary in De Novo mHSPC - Daniel Spratt
UroTodaygeneral

Radiation to the Primary in De Novo mHSPC - Daniel Spratt

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQYlF3LXdVMVFRRlhuYW5KWWo5YUIwblRFeEJhdUVSRGpBZFZrZmdJU0VFclN5a2tDRHlPbng4ck9WaXBsOC1CSmQzOTk3eFNWZ05xVUN6Z0drUDhCVG1BZ3ExUXI2azB5angtVVAwRmxWWEplX3dDR05JZmt0bE9tdG1JZXNWSjZCWkY4aXl0RmNjMFN0dDZLenBEcklsOU14Y3NUa3YzUFVoVWFKSjVsdlk5ZnBPME12?oc=5" target="_blank">Radiation to the Primary in De Novo mHSPC - Daniel Spratt</a>  <font color="#6f6f6f">UroToday</font>

Dr Spratt on the Use of Radiation in Low– and High-Risk Prostate Cancer
OncLivegeneral

Dr Spratt on the Use of Radiation in Low– and High-Risk Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPaXlnSWd1OWpzaXZkekdNYTVDYUh3N09sRURPVmo1dEJTSHNfVFUtM0lBZ21NNzl6elM3WWU2TzhmOTdvZHdaeXR6cmg0ajNMWDVIekVwbTMwd0tPTVZscmVWSU15czVTdGZhLTVFbTFvbUdZYnNpMTJhNGJWT3RHSEZ6cDJXUUw0aUVRY2tmeTY0bFctYXBXUHNka1BvMkV0?oc=5" target="_blank">Dr Spratt on the Use of Radiation in Low– and High-Risk Prostate Cancer</a>  <font color="#6f6f6f">OncLive</font>

Age impacts systemic therapy outcomes in metastatic prostate cancer
News-Medicalgeneral

Age impacts systemic therapy outcomes in metastatic prostate cancer

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQeGFwc0liLW5qNF9yRjJKTTZUUlN2cDlNUGc3NGp3aXJwYU1jMm1VdWxQc1JjaFVHMTg2Q3BVRnhTbTJLaFpLUzN1V28zWFpVaDQzTnBDdGEyMFNQdGZENTZIS1dhbUZPOGx1TTFieHFqMUc0WnlKQnhwRGF5cFE5WFFRVmFaVkotYzA5aGxTR2VtSTFEMFd3YS1DR3hwQkstUm9TaTQyQjJNN1R6SXRzODJFU0NqUQ?oc=5" target="_blank">Age impacts systemic therapy outcomes in metastatic prostate cancer</a>  <font color="#6f6f6f">News-Medical</font>

Daniel Spratt, MD, on using ArteraAI to guide salvage therapy decisions
Urology Timestech

Daniel Spratt, MD, on using ArteraAI to guide salvage therapy decisions

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxOM3lHMXk0aVk0TTByb2RJamVXQU5YMm40NVFjUkwySnVWV2xadFd5QUJUNDZtMWFVSzgzdzduZWJ1QmZJWC1ldmc4ckpzekRGMTRPN2hJbXBMNi01cDBJbVFMUGdrTzk3X2VKTnFDQTh2ZFQ3WmRWOW90djFKRGR6Wkx6ZUFDRDI1aW1ZdzRtbm9ST2h4bnpxMEhsNmZFMWItZEEtMmRR?oc=5" target="_blank">Daniel Spratt, MD, on using ArteraAI to guide salvage therapy decisions</a>  <font color="#6f6f6f">Urology Times</font>

Biomarker-Driven Apalutamide Therapy for Patients With Recurrent Prostate Cancer
The ASCO Postgeneral

Biomarker-Driven Apalutamide Therapy for Patients With Recurrent Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPVEZyMWl3elNqZl9kSFp4UDZyNjMxT2RkWmZQRl9OOWh2eFlLQ0hBRVNkSnB0MVlnckxtQ1RJb1FiRW1PdjV3S1lHNWlsUjVmNXpJa3UwU0U1UjhGcHVKYjV2eVllRzExT3RqTGJMX3oyZmVYWWhsZXFzbnpUV0piMVdrU1BqVV9WdGVzWVNMN0cwOHU3T1pRRHloQUpXSUJBT3I0Q3FZVFVoX2ZFVnVJNmhXVlo2alV2S1NBSTE3dEJGV3c?oc=5" target="_blank">Biomarker-Driven Apalutamide Therapy for Patients With Recurrent Prostate Cancer</a>  <font color="#6f6f6f">The ASCO Post</font>

Daniel E. Spratt, MD, named new Chair of Radiation Oncology for University Hospitals Seidman Cancer Center | Newswise
Newswisetech

Daniel E. Spratt, MD, named new Chair of Radiation Oncology for University Hospitals Seidman Cancer Center | Newswise

<a href="https://news.google.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?oc=5" target="_blank">Daniel E. Spratt, MD, named new Chair of Radiation Oncology for University Hospitals Seidman Cancer Center | Newswise</a>  <font color="#6f6f6f">Newswise</font>

Dr Spratt on Uncertainties Regarding Treatment Intensification in High-Risk Prostate Cancer
OncLivetech

Dr Spratt on Uncertainties Regarding Treatment Intensification in High-Risk Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxPZTROUUwzREZDZk5CRkE2anlmT3VRT1RvWG43S0FmbXdEMkRsMmpwdDdkaElpckoyTFp4UlJOeVpGQW5NdElxckxNNmVCaGhJRVU4QXdIbkx4S29YRWx6azVIUjNjY3Jua05JN2pzWS00ZzJHb3NSTVVmeHYzTnZnODhLM2Q0aU5zOU1KNzFxenNFeUhRbWFQVGRVZEQtVkIyYzFhUDBwd1M2dlh1YmZGRllhYURSQkExRmR4VQ?oc=5" target="_blank">Dr Spratt on Uncertainties Regarding Treatment Intensification in High-Risk Prostate Cancer</a>  <font color="#6f6f6f">OncLive</font>

Dr Spratt on Sequencing Radiation Therapy and Hormone Therapy in Prostate Cancer
OncLivegeneral

Dr Spratt on Sequencing Radiation Therapy and Hormone Therapy in Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNZDZNMFk5cFZld2hacWdIWlRnNXFMX1doVmFUcmdTbmg0bkRsU1ZOdFRpOEdrQ29Kc196V24tVU5KcmhzeGdjUUhvbTh3LU9YVlB3U1JOSGtaOWVIVElvYXBoLTZyZWFOaXFfZTJQRHpsbHlTMm0yUlp0RDZLME1xQVBWM1Nod3VqVFEwaXNsZXlYTjVLUzZMSkpGUGpOSWNYeksyQ2JjZWNmT0M0NWc?oc=5" target="_blank">Dr Spratt on Sequencing Radiation Therapy and Hormone Therapy in Prostate Cancer</a>  <font color="#6f6f6f">OncLive</font>

The Current State of Radiation Oncology "Presentation" - Daniel Spratt
UroTodaygeneral

The Current State of Radiation Oncology "Presentation" - Daniel Spratt

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxQNmVkcVhRMG5tUURTNEJWUFk4dnlWMzRLYTg1NTU4X0tub1plT1hMYVVBMG9GRUJUTnloTXk2S2NuWTNkbGtYWkNoNkVzb0VIZTBzWUswMlRyeTZ3MUZJMEJNQlZPdENGSWtkOGdqNlJPNC14STFiTm4wWDI2blJYQ2s5NlBvTVc0TDRCV2xlbUtCc05yeERJNWlzM2ZTVkxMaThWeWpYVTRKaXBXVXo0bktqVHp0bVNzeGM0dXdPRVVDaE0?oc=5" target="_blank">The Current State of Radiation Oncology "Presentation" - Daniel Spratt</a>  <font color="#6f6f6f">UroToday</font>

Ongoing Research Aims to Enhance Radiotherapy Techniques in Prostate Cancer
OncLivetech

Ongoing Research Aims to Enhance Radiotherapy Techniques in Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQVzJBOVpaaXQwc2x2d0pvMFVuek5aRlZycXEwLUhwQzZDNkVEVGU3VGZOQ1JjdV9PS1BTTXF1Y2dkckhCTTdDNFYtYldWYlBqTmRCVG15SlNWWEFaY182MVE0SEFxSDYydVAxX2R1b00tMUx1QXh4VEM5Q3BKOHNBUGsyVFNTRDdqaVExOW9mUnhJNXE4b1hpNzdid01PNVdBZWI0X2xwcw?oc=5" target="_blank">Ongoing Research Aims to Enhance Radiotherapy Techniques in Prostate Cancer</a>  <font color="#6f6f6f">OncLive</font>

NRG-GU006 Trial for Post-Prostatectomy Radiation Therapy - Daniel Spratt
UroTodaygeneral

NRG-GU006 Trial for Post-Prostatectomy Radiation Therapy - Daniel Spratt

<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxNZllkUHJDeUY1SWR4TDJic1A2SmR6QkpYVUh6TDh2N1RTNTBZR0dXcmlwdGE5c1ZYc20xTzJCQ2NyYzZnYzdZQXFQT0RpYUgtYkhvNm5mQnA5eFpuVEhEclluWTVfaFNic1VyQ0dncXdNOVBDY0l5RkdXSUd3UkJzd3BiR3d4UUM3aVd1Nlhia0tOMmNYQTJMMHM5VWFuYmRNc2lBSnB3RV9FaE5Gdjg0dDgybVozME1LSUNQcnEyRnRXLXdaSmtFRy1NSnUzT0tFQjBN?oc=5" target="_blank">NRG-GU006 Trial for Post-Prostatectomy Radiation Therapy - Daniel Spratt</a>  <font color="#6f6f6f">UroToday</font>

Can We Kill the Bone Scan? "Presentation" - Daniel Spratt
UroTodaygeneral

Can We Kill the Bone Scan? "Presentation" - Daniel Spratt

<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxOQS15WE5WQS1WUGt2enZSUFJGZU1meUxsMWp3dUxMYmlfamVRQlk3ZzVEeFVKNm91S1c4eEtXR3E2NUNSZnhKSHFBdDhLbTN0WVdOdlpUMFBLelZObW1QZEhKeTA1QnI1a05jdjZCS25VSmxDOE5NRlZWTWdnYzAxbXZOV3dJR1ViQ0JYZEhYS1JUZWUzbDRfRzJrQVp6VE9Gc0xCM01CQk9na2I1U290LVA1SklMTDlQQy1OSTA3ZG5nRE1XZDhTblpXMmJ2dkF2NGlySU5B?oc=5" target="_blank">Can We Kill the Bone Scan? "Presentation" - Daniel Spratt</a>  <font color="#6f6f6f">UroToday</font>

Role of Radiation Continues to Grow in the Treatment of Prostate Cancer
OncLivegeneral

Role of Radiation Continues to Grow in the Treatment of Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPc2tBaDVEU2lWV1FXUW9SRTQ0azBiczFsYmhkSVBzR0tlcG8tQVp1TnVCdXB5ZGNaaUlXN0lhVHN3M0JSLVd4dGczVTVTMk96YUpzby1nUnlncVpSSGhBeGxKeC1tU3VjWEkxOFlMZjVUTG9ERWlSUFBUMlljb3hzV3JhTkw4OG5KNy1PdlRvbWlhSlpoNFJ3TXlVeFRpTkZoMmc?oc=5" target="_blank">Role of Radiation Continues to Grow in the Treatment of Prostate Cancer</a>  <font color="#6f6f6f">OncLive</font>

Personalizing Salvage Radiation and Hormone Therapy for Biochemical Recurrence - Daniel Spratt
UroTodaygeneral

Personalizing Salvage Radiation and Hormone Therapy for Biochemical Recurrence - Daniel Spratt

<a href="https://news.google.com/rss/articles/CBMigwJBVV95cUxPM0FmQTU2VTRFeVlLd3AxMDNDcXlxTkg0MjhoamEzMFJjXzdEMldxaHZuQlpKQ0VpemFuYUlzOGlMTE05Wm1tUDgwOXlUUXdsbXRfWHV2cDRlOFdBNnA0UDcxOFlMaXVmcDFjdWhJUk8yYjk5eFBNT3diWVRINXk5MU8xZ0JXOEpoTW9fYzBsX0NUS3pZVVoxal9yZ3M0NGQzcXhWSjlPYll4UV92cmJVYXRoZzhqUW1rYzJkTEZPbjRJMWhDbVE2SW1OaUhGQURjUVhtcHNILWZKaHRFai1rcjNlMXF4a0k5ME5RUVA4V1UwVzBpc2lCVTQ2OHk3VWlyaWZR?oc=5" target="_blank">Personalizing Salvage Radiation and Hormone Therapy for Biochemical Recurrence - Daniel Spratt</a>  <font color="#6f6f6f">UroToday</font>

Combining Genomic Classifier and Digital Pathology Artificial Intelligence in Prostate Cancer Risk Stratification - Daniel Spratt
UroTodaygeneral

Combining Genomic Classifier and Digital Pathology Artificial Intelligence in Prostate Cancer Risk Stratification - Daniel Spratt

<a href="https://news.google.com/rss/articles/CBMiswJBVV95cUxOM01xS3h3eFkxeS0xclJ0RTVvZkxoUDI1TDlfRWYtSmhONGphVTlNcC1wRFlucEhIdFBCQlhqLV96ZDJEbW9CYjFnSFNuNmZFSFYxOGRSNE1uMzgycEc2bDMwTW92eG1TaVRQc1BvOXFBZkU0R3g1YTFLczJaR2wxSzNkVm91VDlfRi05cTRwRnl4THdITkJVRFlHY0lrWGwxY05vaUhvV0szOHh4eW91Z3pJdEtZYnk0VXlFb2VsWUVDT0owZGxnXzdaWEV3UXJhX3dDalFQdjZ6YVVJQ0d6ZGVBS19MbEloTEZmYUpKNHRnaHZ1djNOa2FqaC1GWkNycUluYmJBcmRjTXI2QjlzM1RHVjlCV0xNVWVQUl9CV2JZbzhZV0UxVGRzWi1naUV2eDBn?oc=5" target="_blank">Combining Genomic Classifier and Digital Pathology Artificial Intelligence in Prostate Cancer Risk Stratification - Daniel Spratt</a>  <font color="#6f6f6f">UroToday</font>

ASTRO 2025: Quantifying the Benefits of Adding Androgen Deprivation Therapy versus Dose-Escalation for Prostate Cancer
UroTodaygeneral

ASTRO 2025: Quantifying the Benefits of Adding Androgen Deprivation Therapy versus Dose-Escalation for Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMiugJBVV95cUxOMUtweVl0bUxfTGpBNDBPdTRTREY5eUt0bGNyaEMwN3RwN29uTndIZlRzZDg0c2xILVNPd0RhZ0JOWDZYYVEtZXVmd2dGZEY1MDZyZjl0b0tQb1BJeGZ1UDdZa2MzNVlkT3ZnVVZ6ZXR3TTlvZ3lrbFlPRGZZSHliNkpaTXVsRVYzWWlvTUlrYm1FLVNwUjNpRUxRN0htMG9fUkRjZjdURUd6N1ZlTzVjNFllSXQ1eFlDYWJ6TU9RZzBTRF9BUkxQa25RU2JwZEVUX2FUQ2gzX0x2MVdYRERHRDFuVVZrMWxJcEtsVU4tUnlRZ3h4NXJnLUZvV0xIc1F0bllCQWlfTEVrY1JNajJaTy1UaTY1NUtxLXVBa3dDUklVYmNfS0FUaktKWHctWVZRNElyVDFFWThDQQ?oc=5" target="_blank">ASTRO 2025: Quantifying the Benefits of Adding Androgen Deprivation Therapy versus Dose-Escalation for Prostate Cancer</a>  <font color="#6f6f6f">UroToday</font>

Dr. Shoag and Dr. Spratt discuss SpaceOAR Center of Excellence distinction
Urology Timesscience

Dr. Shoag and Dr. Spratt discuss SpaceOAR Center of Excellence distinction

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUDB5MG1hR21zLW5CMEtSSFAyYms2WkViYkJ6R3pvc2RLQXFnbkJFa3RUZldyWmNucGp4WDZMdWJoTWViU0x2ZHBaV2dkbUhZT1FtUU1DSjl6YlJsMENfOVludVFFUTF3Q015WDlHYWlVLUxST19xMHZsYmZQOUpqWVE1aFFoYVJPbVU1RXFWNmpQSTlmRmtDLTlPVGNXQ3ZKaG1yOEpRS2ltZw?oc=5" target="_blank">Dr. Shoag and Dr. Spratt discuss SpaceOAR Center of Excellence distinction</a>  <font color="#6f6f6f">Urology Times</font>

Multi-Modal Artificial Intelligence (MMAI) Prognostic Biomarker in High-Risk Prostate Cancer - Daniel Spratt
UroTodaytech

Multi-Modal Artificial Intelligence (MMAI) Prognostic Biomarker in High-Risk Prostate Cancer - Daniel Spratt

<a href="https://news.google.com/rss/articles/CBMiqwJBVV95cUxPclJmU1JublF0aS15blFpT25wUU8yVDNEcjdqZDZveEswb2NDM2h6NXBCb3hUcHNtRks3bzFHMzlwalhmdlk5ZmM3LU83VXBObDVicXZOTDdtcTMwM0s1TWZKS3VROWtEWjRxb0pxdmhDVnk1NTNjZjJmSkwxNUhCNHN2NUlYNnk1SU5mSElHWjkwVFVESGdqcE1NaHpkZml2cElGbnRfQkEycjNDbkVhSC0yV1hJUTg5SGlGeXR4LXlOZ3FTTFFHUFJiUjd2cE1lSmlzMFVNYzEwZ1JVVmplTlhQMFRoV09HaGxVTXk3X3FpZ0xZNDVXdk9fcW9GYkswNGFnNUJoaG9vNG04V1Y3aG5iQ3ZaS3ozUVM0akM1MlNuU0MyLXowWVRaWQ?oc=5" target="_blank">Multi-Modal Artificial Intelligence (MMAI) Prognostic Biomarker in High-Risk Prostate Cancer - Daniel Spratt</a>  <font color="#6f6f6f">UroToday</font>

What is the Evidence of MDT in Synchronous vs Metachronous mHSPC? APCCC 2022 Presentation - Daniel Spratt
UroTodaygeneral

What is the Evidence of MDT in Synchronous vs Metachronous mHSPC? APCCC 2022 Presentation - Daniel Spratt

<a href="https://news.google.com/rss/articles/CBMiqAJBVV95cUxQa0doZGJrenBlbnJmSnRaQm04NGNfRFk0eTIyNExhR1NhWk55QUNxVUprbnU4bW1VWUNRZ3UxZWhRV3BoUXJwMmZseGNuTExZSTZFMHNRblU4RVdiYWlMQlZMUi15dzVUcURXMEVKbEpqaDJ3LVA2S1JaSnZpV1M4SzlDanpFeTlyam9rb0NiS2VvT3ZSUmplVDE3dEo2NXZBUlVOMW50MkNtZUxWUnlTc1NkMk14MUJNdzFqSnZzTWswTVNLc1JycFBkV1dRQXVfUURERDBONnRxVWRHVXd0YWx3Y2ZySXY2YUV6R0lyRWlESFUyc0kyQWFpU1ZBU1V2NmZaRDd5aWtXUm9ENGhiNmI0eWYzbFp5aEZia0M0TnFVZGVicm41ag?oc=5" target="_blank">What is the Evidence of MDT in Synchronous vs Metachronous mHSPC? APCCC 2022 Presentation - Daniel Spratt</a>  <font color="#6f6f6f">UroToday</font>

Daniel E. Spratt, MD, on Prostate Cancer: Short-Term Adjuvant vs Neoadjuvant Hormone Therapy
The ASCO Postgeneral

Daniel E. Spratt, MD, on Prostate Cancer: Short-Term Adjuvant vs Neoadjuvant Hormone Therapy

<a href="https://news.google.com/rss/articles/CBMi0AJBVV95cUxQSy1HamxxbWlvbjVySXdOdUxjMV9hd2JxSXAtN2RpcnpDNWxrRmJxa2tzMlpPSFowa2M1anNHZDVOa3VHcGpuYlBDcVJneExTeUFsT1J5RE0xbVQ1T1hNLUtpM1gxN3h5ek9Dd3pmSTlRS01UUE1Vd2JrRlc2RzlpUHBuY1dwTndyc0dlQVM3QXBXVXFabEVFT1R2QW8yeUtwclM2Yzh4V054Qkk5U3B3UVNqamRtWWduVUtSdzBRYm9kZnV5U1JoTU4zRGZaZ0VEdmRPNnRzYUNITnIycHlhdXZPcEh1LTd4eUJXWEZJYjM3N0h6ak9Vcm16c1FRalc4NDM2MjVuMUctV005VXd0MmI4UTZoUlUzeXgyVjRadEtOb1lDQ0NscllCeV9DSEtkUDQzZDVETTd2N1hTSjB3RVJ3WDNzYzdELUFmbVJVMUI?oc=5" target="_blank">Daniel E. Spratt, MD, on Prostate Cancer: Short-Term Adjuvant vs Neoadjuvant Hormone Therapy</a>  <font color="#6f6f6f">The ASCO Post</font>

The Role of ADT in Men Being Treated with Radiation Therapy - Daniel Spratt
UroTodaygeneral

The Role of ADT in Men Being Treated with Radiation Therapy - Daniel Spratt

<a href="https://news.google.com/rss/articles/CBMiiAJBVV95cUxQN0s0bUF0TEJTZUZyQVRsVkRHTWpwRy15WlVJZndZa2dTWENvZHVhYkpYdUpRaGpVWFN5cXZBRlhKalhsdG5EOXdFczRqVjRPbENIR2ZKQlNIcDVJUFBrNXVjejF5MWJUQXphd0NTNFVnZjI5NmtzT2ZMZXZJMUM1T0t3dDlWX0h4V0I2Tmp2bHh4YlVZV3JXVnJXTC1IX3VXOVo0aFJrdDBHaXhYOHh1NTZXcjlWLTdxWS1pVnZIWm5BOWlTeExlc1o0WHNwSVdJSjI3ODFLdVhpdmx2RHJ0ckFtM05KdFFfREVYUFJBNnA2SDU0WDlFc3hhT3h4VnFqel9GS19tTlo?oc=5" target="_blank">The Role of ADT in Men Being Treated with Radiation Therapy - Daniel Spratt</a>  <font color="#6f6f6f">UroToday</font>

University Hospitals Seidman Cancer Center is one of the first in North America to offer Varian Ethos 2.0 for cancer patients
University Hospitalsworld

University Hospitals Seidman Cancer Center is one of the first in North America to offer Varian Ethos 2.0 for cancer patients

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE9aQjJqUHY0XzAyS1liVHk1Zlp1RFZUQXlqUWRBdFJ1cXlCQW1ENU1SbFlXaXlOb0xDcGtvc1VSbVJ3d1kzRzdSYnl5NnFieTFqQ1l5NHJfdVVXZmdiWmZmN1JvT0FuWURqWXVGV1NKOFlnS0ty?oc=5" target="_blank">University Hospitals Seidman Cancer Center is one of the first in North America to offer Varian Ethos 2.0 for cancer patients</a>  <font color="#6f6f6f">University Hospitals</font>

Correlation and Validation of Gene Expression Classifiers in Prostate Cancer: A Large-Scale Study - Daniel Spratt
UroTodaygeneral

Correlation and Validation of Gene Expression Classifiers in Prostate Cancer: A Large-Scale Study - Daniel Spratt

<a href="https://news.google.com/rss/articles/CBMiugJBVV95cUxNdU4xT044OXZxM29oeDVpbFRhTW5MeFI3c0tpaWs5Y0ZqdEhDMTA2eGctYm9OdjlQYk15THJpa2liTk1ZOEo4aGp1bllLUnVsVUFVNkV6TDVFUHhEV1hzRjJpQUxhLUlBSUFuTW5wRkp1ZllqdGtRRWZ6aVZlMTZwUElvNHlxYW9zbWMwX1ZSbHNhZm5pazByb29oZ3paOVhGdDF5MUlVc2psUTdiXzdDVFF6a05Icm1XNS0tb1BJUW15Sm1TcWY5TWlSdjBNWkdPejI1UXBEY3RwTkpuWXpUdUhiMEtZVG1wVEU5WFFwQ0l4Wjg4dl9GQ1pfVjN2R3hFTUprNkEwMTkwQWV0bk1vTkRER3J2bl9KTE1UZnNBcm1XODVReHNyeTEwTGQ4VHhEekFsNkZTVk04QQ?oc=5" target="_blank">Correlation and Validation of Gene Expression Classifiers in Prostate Cancer: A Large-Scale Study - Daniel Spratt</a>  <font color="#6f6f6f">UroToday</font>

Sharing Clinical Information through Social Media - Todd Morgan & Daniel Spratt
UroTodaygeneral

Sharing Clinical Information through Social Media - Todd Morgan & Daniel Spratt

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxPd0V4LTdycnVGd09xYklNZnVSNDdyZVE0bTJxMUdoQVI2bjNtazJIWTl3OG05elozUWJSMVAzMjYzQmpkdzNDUmlLQjlQVkkwenJKZklQekYxcFFtNV8tVDllYXFyS3B4M2l0Y1BxWERhOTZBUTVvRnlnZk1QRlQ5ZDVacGdEa0VlNzNvQmVGRk9TOW0xanRaV0Z2cFhNRGVfamExNEFsRTJQdlZPcjdXX1RQQ2ZNaHJ1ekR1TnpYMXI2OXRQU0JET0VOc19SUC1Rb1otZmJxem1jSl9H?oc=5" target="_blank">Sharing Clinical Information through Social Media - Todd Morgan & Daniel Spratt</a>  <font color="#6f6f6f">UroToday</font>

Dr. Spratt on an AI model predictive of hormone therapy benefit in men with prostate cancer
Urology Timestech

Dr. Spratt on an AI model predictive of hormone therapy benefit in men with prostate cancer

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNTmtKNkdJSHA0cl9QWlZhQ2RTVGdpam05aURnZWV0a2pOZFFTSFVtWGkwVFNvcFVsSzIwcEYtSzZ5UWhDN3EwMG5GcTdncVkxQlNHNjNxc2c4X1FuOGRZTG5hUk1MQzhYYktkWi1ULVhVYjNwMXp5VEQwcmF0VDBHZEMwbHZOSG9peWlpZG5tY29UUjVpN0NFR3VHYXlXN1ZhV2kwQ3VsZ3JadUxDR24yWFBOMFJkOHUtZ28yWlFySmJ6UQ?oc=5" target="_blank">Dr. Spratt on an AI model predictive of hormone therapy benefit in men with prostate cancer</a>  <font color="#6f6f6f">Urology Times</font>

ASCO GU 2025: Risk Stratification Using the Decipher® 22-Gene Genomic Classifier and Digital Pathology Artificial Intelligence in Nearly 10,000 Localized Prostate Cancer Patients
UroTodaygeneral

ASCO GU 2025: Risk Stratification Using the Decipher® 22-Gene Genomic Classifier and Digital Pathology Artificial Intelligence in Nearly 10,000 Localized Prostate Cancer Patients

<a href="https://news.google.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?oc=5" target="_blank">ASCO GU 2025: Risk Stratification Using the Decipher® 22-Gene Genomic Classifier and Digital Pathology Artificial Intelligence in Nearly 10,000 Localized Prostate Cancer Patients</a>  <font color="#6f6f6f">UroToday</font>

Daniel Spratt, MD (IMAGE)
EurekAlert! Science News Releasesgeneral

Daniel Spratt, MD (IMAGE)

<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE5IVmZLdFFDa0d3NzJMZTNodlFvSW1Sb1hqUWxCRTE1eEctdWpBRGNmS19tM1NZZzBKN3NQZFRnYWw0SkJ6bDEwcVo0Mm14NGpHN0tHQS1LVQ?oc=5" target="_blank">Daniel Spratt, MD (IMAGE)</a>  <font color="#6f6f6f">EurekAlert! Science News Releases</font>

"Daniel Spratt, MD" — Live Google News Trends & Headlines